Literature DB >> 22940493

Prevalence and risk factors for cervical HPV infection and abnormalities in young adult women at enrolment in the multinational PATRICIA trial.

Edith Roset Bahmanyar1, Jorma Paavonen, Paulo Naud, Jorge Salmerón, Song-Nan Chow, Dan Apter, Henry Kitchener, Xavier Castellsagué, Julio C Teixeira, S Rachel Skinner, Unnop Jaisamrarn, Genara A Limson, Suzanne M Garland, Anne Szarewski, Barbara Romanowski, Fred Aoki, Tino F Schwarz, Willy A J Poppe, Newton S De Carvalho, Diane M Harper, F Xavier Bosch, Alice Raillard, Dominique Descamps, Frank Struyf, Matti Lehtinen, Gary Dubin.   

Abstract

OBJECTIVE: We evaluated baseline data from the PApilloma TRIal against Cancer In young Adults (PATRICIA; NCT00122681) on the association between behavioral risk factors and HPV infection and cervical abnormalities.
METHODS: Women completed behavioral questionnaires at baseline. Prevalence of HPV infection and cervical abnormalities (detected by cytological or histological procedures) and association with behavioral risk factors were analyzed by univariate and stepwise multivariable logistic regressions.
RESULTS: 16782 women completed questionnaires. Among 16748 women with data for HPV infection, 4059 (24.2%) were infected with any HPV type. Among 16757 women with data for cytological abnormalities, 1626 (9.7%) had a cytological abnormality, of whom 1170 (72.0%) were infected with at least one oncogenic HPV type including HPV-16 (22.7%) and HPV-18 (9.3%). Multivariable analysis (adjusted for age and region, N=14404) showed a significant association between infection with any HPV type and not living with a partner, smoking, age <15 years at first sexual intercourse, higher number of sexual partners during the past 12 months, longer duration of hormonal contraception and history of sexually transmitted infection (STI). For cervical abnormalities, only history of STI (excluding Chlamydia trachomatis) remained significant in the multivariable analysis after adjusting for HPV infection.
CONCLUSIONS: Women reporting 3+ sexual partners in the past 12 months had the highest risk of HPV infection at baseline. HPV infection was the main risk factor for cervical abnormalities, and history of STIs excluding Chlamydia trachomatis increased risk to a lesser extent. Although behavioral factors can influence risk, all sexually active women are susceptible to HPV infection.
Copyright © 2012 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22940493     DOI: 10.1016/j.ygyno.2012.08.033

Source DB:  PubMed          Journal:  Gynecol Oncol        ISSN: 0090-8258            Impact factor:   5.482


  28 in total

1.  Association between human papillomavirus and chlamydia trachomatis infection risk in women: a systematic review and meta-analysis.

Authors:  Giulia Naldini; Chiara Grisci; Manuela Chiavarini; Roberto Fabiani
Journal:  Int J Public Health       Date:  2019-06-08       Impact factor: 3.380

Review 2.  What is the best way to manage screening for infections and vaccination of inflammatory bowel disease patients?

Authors:  Gianluca Andrisani; Alessandro Armuzzi; Manuela Marzo; Carla Felice; Daniela Pugliese; Alfredo Papa; Luisa Guidi
Journal:  World J Gastrointest Pharmacol Ther       Date:  2016-08-06

3.  Prevalence and Determinants of High-risk HPV Infection among 11549 Women from an Opportunistic Screening in Hubei Province.

Authors:  Quan-Fu Ma; Yu-Lin Guo; Han Gao; Bin Yan; Xuan Dai; Meng Xu; Yu-Jing Xiong; Qiu-Zi Peng; Ying Wang; Miao Zou; Xu-Feng Wu
Journal:  Curr Med Sci       Date:  2019-07-25

4.  Risk factors for cervical precancer detection among previously unscreened HIV-infected women in Western Kenya.

Authors:  Megan J Huchko; Hannah Leslie; Jennifer Sneden; May Maloba; Naila Abdulrahim; Elizabeth A Bukusi; Craig R Cohen
Journal:  Int J Cancer       Date:  2013-09-13       Impact factor: 7.396

Review 5.  A Review on the Use of the HPV Vaccine in the Prevention of Cervical Cancer.

Authors:  Pranav Pathak; Sandhya Pajai; Himanshi Kesharwani
Journal:  Cureus       Date:  2022-09-02

6.  Prevalence and risk factors associated with precancerous cervical lesions among women in two cities in Cameroon.

Authors:  Bernard Wabo; Dickson Shey Nsagha; Théophile Njamen Nana; Clement Jules Nguedia Assob
Journal:  Pan Afr Med J       Date:  2022-04-06

Review 7.  The impact of smoking on HPV infection and the development of anogenital warts.

Authors:  Reto Kaderli; Beat Schnüriger; Lukas E Brügger
Journal:  Int J Colorectal Dis       Date:  2014-06-17       Impact factor: 2.571

8.  Risk of newly detected infections and cervical abnormalities in women seropositive for naturally acquired human papillomavirus type 16/18 antibodies: analysis of the control arm of PATRICIA.

Authors:  Xavier Castellsagué; Paulo Naud; Song-Nan Chow; Cosette M Wheeler; Maria Julieta V Germar; Matti Lehtinen; Jorma Paavonen; Unnop Jaisamrarn; Suzanne M Garland; Jorge Salmerón; Dan Apter; Henry Kitchener; Julio C Teixeira; S Rachel Skinner; Genara Limson; Anne Szarewski; Barbara Romanowski; Fred Y Aoki; Tino F Schwarz; Willy A J Poppe; F Xavier Bosch; Newton S de Carvalho; Klaus Peters; Wiebren A A Tjalma; Mahboobeh Safaeian; Alice Raillard; Dominique Descamps; Frank Struyf; Gary Dubin; Dominique Rosillon; Laurence Baril
Journal:  J Infect Dis       Date:  2014-03-08       Impact factor: 5.226

9.  Genital human papillomavirus infection among women in Bangladesh: findings from a population-based survey.

Authors:  Quamrun Nahar; Farhana Sultana; Anadil Alam; Jessica Yasmine Islam; Mustafizur Rahman; Fatema Khatun; Nazmul Alam; Sushil Kanta Dasgupta; Lena Marions; Mohammed Kamal; Alejandro Cravioto; Laura Reichenbach
Journal:  PLoS One       Date:  2014-10-01       Impact factor: 3.240

10.  Natural history of progression of HPV infection to cervical lesion or clearance: analysis of the control arm of the large, randomised PATRICIA study.

Authors:  Unnop Jaisamrarn; Xavier Castellsagué; Suzanne M Garland; Paulo Naud; Johanna Palmroth; Maria Rowena Del Rosario-Raymundo; Cosette M Wheeler; Jorge Salmerón; Song-Nan Chow; Dan Apter; Julio C Teixeira; S Rachel Skinner; James Hedrick; Anne Szarewski; Barbara Romanowski; Fred Y Aoki; Tino F Schwarz; Willy A J Poppe; F Xavier Bosch; Newton S de Carvalho; Maria Julieta Germar; Klaus Peters; Jorma Paavonen; Marie-Cecile Bozonnat; Dominique Descamps; Frank Struyf; Gary O Dubin; Dominique Rosillon; Laurence Baril
Journal:  PLoS One       Date:  2013-11-19       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.